Inhibition of NAMPT by specific inhibitors, such as FK866, or its down-regulation by siRNA reduces intracellular NAD+ level and decreases cancer cell growth in both in vitro and in vivo models [5, 7, 10, 11, 15]. Here, NAMPT is linked to cancer.